Osteoarthritis and ageing

Ageing is a complex process of accumulation of molecular, cellular, and organ damage, leading to loss of function and increased vulnerability to disease and death, the rate and extent of which varies among individuals. Osteoarthritis (OA) is not only the most common joint disease, but is also one of...

Full description

Bibliographic Details
Main Authors: Valdes, Ana M., Stocks, Joanne
Format: Article
Language:English
Published: European Medical Group 2018
Subjects:
Online Access:https://eprints.nottingham.ac.uk/50979/
_version_ 1848798383566749696
author Valdes, Ana M.
Stocks, Joanne
author_facet Valdes, Ana M.
Stocks, Joanne
author_sort Valdes, Ana M.
building Nottingham Research Data Repository
collection Online Access
description Ageing is a complex process of accumulation of molecular, cellular, and organ damage, leading to loss of function and increased vulnerability to disease and death, the rate and extent of which varies among individuals. Osteoarthritis (OA) is not only the most common joint disease, but is also one of the major causes of disability in people aged >65 years and is accompanied by comorbid conditions, increased mortality, and decreased quality of life. One of the major risk factors for OA is ageing. However, OA itself may be involved in the biological ageing process. This is likely to be in part a direct involvement, by contributing levels of systemic inflammation and sharing molecular pathways with biological ageing, such as mitochondrial damage leading to cell senescence. Although OA is not considered an inflammatory form of arthritis, there is evidence of subclinical low-grade inflammation in the whole joint and inflammatory processes play a key role in the disease pathogenesis. For instance, there is synovial inflammation (e.g., following injury), mechanically derived inflammation present due to biomechanical overloading of a joint, and systemic inflammation resulting from obesity. Systemic inflammation is often associated with frailty, and having a high concentration of inflammatory markers is predictive of incident frailty, some of which are known to increase with age and correlate with pain. In addition, OA may also contribute indirectly to biological ageing via the disability and pain resulting from it. Further research into the exact process linking OA and biological ageing, including frailty, is needed.
first_indexed 2025-11-14T20:18:54Z
format Article
id nottingham-50979
institution University of Nottingham Malaysia Campus
institution_category Local University
language English
last_indexed 2025-11-14T20:18:54Z
publishDate 2018
publisher European Medical Group
recordtype eprints
repository_type Digital Repository
spelling nottingham-509792018-04-10T01:35:38Z https://eprints.nottingham.ac.uk/50979/ Osteoarthritis and ageing Valdes, Ana M. Stocks, Joanne Ageing is a complex process of accumulation of molecular, cellular, and organ damage, leading to loss of function and increased vulnerability to disease and death, the rate and extent of which varies among individuals. Osteoarthritis (OA) is not only the most common joint disease, but is also one of the major causes of disability in people aged >65 years and is accompanied by comorbid conditions, increased mortality, and decreased quality of life. One of the major risk factors for OA is ageing. However, OA itself may be involved in the biological ageing process. This is likely to be in part a direct involvement, by contributing levels of systemic inflammation and sharing molecular pathways with biological ageing, such as mitochondrial damage leading to cell senescence. Although OA is not considered an inflammatory form of arthritis, there is evidence of subclinical low-grade inflammation in the whole joint and inflammatory processes play a key role in the disease pathogenesis. For instance, there is synovial inflammation (e.g., following injury), mechanically derived inflammation present due to biomechanical overloading of a joint, and systemic inflammation resulting from obesity. Systemic inflammation is often associated with frailty, and having a high concentration of inflammatory markers is predictive of incident frailty, some of which are known to increase with age and correlate with pain. In addition, OA may also contribute indirectly to biological ageing via the disability and pain resulting from it. Further research into the exact process linking OA and biological ageing, including frailty, is needed. European Medical Group 2018-03-01 Article PeerReviewed application/pdf en cc_by_nc https://eprints.nottingham.ac.uk/50979/1/Osteoarthritis-and-Ageing%20%20EMJ%20Valdes%20and%20Stocks%202018.pdf Valdes, Ana M. and Stocks, Joanne (2018) Osteoarthritis and ageing. European Medical Journal Rheumatology, 3 (1). pp. 116-123. ISSN 2056-6395 Osteoarthritis Ageing Frailty Inflammation Pain https://www.emjreviews.com/rheumatology/article/osteoarthritis-and-ageing/
spellingShingle Osteoarthritis
Ageing
Frailty
Inflammation
Pain
Valdes, Ana M.
Stocks, Joanne
Osteoarthritis and ageing
title Osteoarthritis and ageing
title_full Osteoarthritis and ageing
title_fullStr Osteoarthritis and ageing
title_full_unstemmed Osteoarthritis and ageing
title_short Osteoarthritis and ageing
title_sort osteoarthritis and ageing
topic Osteoarthritis
Ageing
Frailty
Inflammation
Pain
url https://eprints.nottingham.ac.uk/50979/
https://eprints.nottingham.ac.uk/50979/